Development, Validation, and Comparison of Two Mass Spectrometry Methods (LC-MS/HRMS and LC-MS/MS) for the Quantification of Rituximab in Human Plasma

Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers

(2020) Angelo Paci et al.   EUROPEAN JOURNAL OF CANCER

Analytical and functional similarity of biosimilar ABP 798 with rituximab reference product

(2020) Neungseon Seo et al.   BIOLOGICALS

Simultaneous quantification of rituximab and eculizumab in human plasma by liquid chromatography-tandem mass spectrometry and comparison with rituximab ELISA kits

(2020) Aurélie Truffot et al.   CLINICAL BIOCHEMISTRY

A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease

(2019) Théo Willeman et al.   ANALYTICA CHIMICA ACTA

Six-step workflow for the quantification of therapeutic monoclonal antibodies in biological matrices with liquid chromatography mass spectrometry – A tutorial

(2019) Mohsin El Amrani et al.   ANALYTICA CHIMICA ACTA

Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue Syndrome

(2018) Ingrid G. Rekeland et al.   CLINICAL THERAPEUTICS

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis

(2016) John R. Mills et al.   ANALYTICAL CHEMISTRY

Validated LC/MS Bioanalysis of Rituximab CDR Peptides Using Nano-surface and Molecular-Orientation Limited (nSMOL) Proteolysis

(2016) Noriko Iwamoto et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

A Novel and Cost Effective Method of Removing Excess Albumin from Plasma/Serum Samples and Its Impacts on LC-MS/MS Bioanalysis of Therapeutic Proteins

(2014) Guowen Liu et al.   ANALYTICAL CHEMISTRY

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

(2014) Loïc Guillevin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280586 and Rituximab (MabThera®)

(2014) Anne M. Ryan et al.   TOXICOLOGIC PATHOLOGY

Application of high-resolution MS in the quantification of a therapeutic monoclonal antibody in human plasma

(2014) Kevork Mekhssian et al.   Bioanalysis

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

(2013) Jan Visser et al.   BIODRUGS

Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus

(2013) V. Reddy et al.   RHEUMATOLOGY

Combinatorial Chemotherapeutic Efficacy in Non-Hodgkin Lymphoma Can Be Predicted by a Signaling Model of CD20 Pharmacodynamics

(2012) J. M. Harrold et al.   CANCER RESEARCH

Validation of a gyrolab™ assay for quantification of rituximab in human serum

(2012) Xiaodong F. Liu et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies

(2011) G. Cartron et al.   CLINICAL CANCER RESEARCH

N-terminal Glutamate to Pyroglutamate Conversionin Vivofor Human IgG2 Antibodies

(2011) Y. Diana Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects

(2010) G. Hampson et al.   JOURNAL OF IMMUNOLOGICAL METHODS